The experimental CAR T-cell therapy treatment was given as part of a clinical trial that's enrolling adults with progressive ...

Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...

Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow ...

A study found neurofilament light chain at high levels in the blood and CSF of MS patients, suggesting its potential as a ...

Columnist Desiree Lama describes her unexpected joy at having a new cat join her existing feline friend, especially when they ...

Medications that promote repair of the myelin sheath that protects nerve cells may help limit damage due to MS, a trial ...

Women in their childbearing years are significantly less likely than men in the same age range to be given disease-modifying ...

Susan Payrovi, MD, and Mirla Avila, MD, discuss early gut microbiome formation and its lifelong influence on MS and immune ...

Three prevalent symptoms in MS – fatigue, mobility and cognitive impairment – generally aren't barriers to healthy habits, a ...

Guest writer Denise Schnieders sounds the alarm as U.S. lawmakers continue to eliminate funding for key MS research programs.

The effort to explore the genetic link between the Epstein-Barr virus and the risk of developing MS was awarded a $24,400 ...

Columnist Susan Payrovi, MD, discusses the importance of prioritizing play. For her, it's a key source of physical and mental ...